GlycoMimetics
Develop treatments for diseases as sickle cell and cancer.
Launch date
Employees
Market cap
€10.0m
Enterprise valuation
(€10m) (Public information from Sep 2024)
Share price
$0.17 GLYC
Gaithersburg Maryland (HQ)
Authorizing premium user...